BioAge Labs Inc

BIOANASDAQ · USD
8.46USD0.00 (+4.58%)
5310

BioAge Labs Inc (BIOA) Option Chain

As of September 22, 2026, BioAge Labs Inc is trading at $8.46, a +4.58% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 60.5%. IV Rank is 3%.

Read more

Tracking the BIOA option chain helps you see every strike and expiry on BioAge Labs Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. BioAge Labs Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BIOA options activity at a glance. Use our scanner to monitor the BIOA option chain in real time and filter for the BIOA options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BIOA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the BIOA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where BIOA stock options are being actively traded and where they are not.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation.

The company was incorporated in 2015 and is based in Richmond, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls BioAge Labs Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen BIOA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of BIOA stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile30.56% Subdued
  • Market cap (M$)388
  • 52 weeks high-67.41%
  • 52 weeks low72.65%
  • Analyst recommendationStrong Buy
    1.44
  • Target price$35.62
    321.04% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-2.39
  • EPS growth next 5 years-4.63%

As of September 22, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0000-0.165.963.508.102.50-70.450.050.000.0500100.00
0.0400-0.213.461.005.505.00-40.900.050.000.050299.96
23.551,11500.060.960.351.707.50-11.350.100.300.000.2005276.45
87.3947501.150.001.1510.00+18.200.104.901.540.9608112.61
99.521100.150.000.1512.50+47.752.006.504.040.21080.48

As of September 22, 2026

Scan the full option chain in one place

Browse the full BIOA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial